In vitro safety “clinical trial” of the cardiac liability of drug polytherapy

Only a handful of US Food and Drug Administration (FDA) Emergency Use Authorizations exist for drug and biologic therapeutics that treat severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) infection. Potential therapeutics include repurposed drugs, some with cardiac liabilities. We report o...

Descripción completa

Detalles Bibliográficos
Autores principales: Charrez, Bérénice, Charwat, Verena, Siemons, Brian, Finsberg, Henrik, Miller, Evan W., Edwards, Andrew G., Healy, Kevin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212738/
https://www.ncbi.nlm.nih.gov/pubmed/33786981
http://dx.doi.org/10.1111/cts.13038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212738/
https://www.ncbi.nlm.nih.gov/pubmed/33786981
http://dx.doi.org/10.1111/cts.13038

Ejemplares similares